Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (81-90 of 825) with videos related to

Pageof 83
Sort By:
Hematology/Oncology Clinics of North America|February 1, 1992
Chemotherapy for muscle-infiltrating bladder cancerH I Scher, P W Kantoff
The Journal of Clinical Investigation|August 1, 1981
Autologous rosette-forming T cells regulate responses of T cells. Phenotypic and functional analysis of suppressor cells generated from autologous rosette-forming T cells after autologous mixed lymphocyte reactionsS Kumagai, I Scher, I Green
Nature Reviews. Clinical Oncology|November 11, 2015
CHAARTED/GETUG 12--docetaxel in non-castrate prostate cancersMin Yuen Teo, Howard I Scher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancerKaren E Knudsen, Howard I Scher
British Journal of Cancer|October 23, 2018
Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC)Min Yuen Teo, Howard I Scher
The Journal of Urology|June 17, 1998
Interstitial pneumonitis following bicalutamide treatment for prostate cancerJ A McCaffrey, H I Scher
The Oncologist|April 17, 2003
Clinical approaches to osseous metastases in prostate cancerMichael J Morris, Howard I Scher
Critical Reviews in Oncology/Hematology|July 10, 2003
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer CenterMichael J Morris, Howard I Scher
Cephalalgia : an International Journal of Headache|March 23, 2012
High migraine prevalence in Parma: why?Larus S Gudmundsson, Ann I Scher
Seminars in Oncology|October 1, 1990
Chemotherapy for invasive bladder cancer: introductionH I Scher, T A Splinter
Pageof 83

Showing results (81-90 of 825) with videos related to

Sort By:
Pageof 83
Hematology/Oncology Clinics of North America|February 1, 1992
Chemotherapy for muscle-infiltrating bladder cancerH I Scher, P W Kantoff
The Journal of Clinical Investigation|August 1, 1981
Autologous rosette-forming T cells regulate responses of T cells. Phenotypic and functional analysis of suppressor cells generated from autologous rosette-forming T cells after autologous mixed lymphocyte reactionsS Kumagai, I Scher, I Green
Nature Reviews. Clinical Oncology|November 11, 2015
CHAARTED/GETUG 12--docetaxel in non-castrate prostate cancersMin Yuen Teo, Howard I Scher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancerKaren E Knudsen, Howard I Scher
British Journal of Cancer|October 23, 2018
Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC)Min Yuen Teo, Howard I Scher
The Journal of Urology|June 17, 1998
Interstitial pneumonitis following bicalutamide treatment for prostate cancerJ A McCaffrey, H I Scher
The Oncologist|April 17, 2003
Clinical approaches to osseous metastases in prostate cancerMichael J Morris, Howard I Scher
Critical Reviews in Oncology/Hematology|July 10, 2003
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer CenterMichael J Morris, Howard I Scher
Cephalalgia : an International Journal of Headache|March 23, 2012
High migraine prevalence in Parma: why?Larus S Gudmundsson, Ann I Scher
Seminars in Oncology|October 1, 1990
Chemotherapy for invasive bladder cancer: introductionH I Scher, T A Splinter
Pageof 83